CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

The Harvard Drug Group LLC recalls Memantine Hydrochloride…

The Harvard Drug Group LLC recalls Memantine Hydrochloride Extended-Release

Read the official FDA notice

Published
22 Apr 2026
Units affected
N/A
Agency
FDA
Country
United States

The hazard

Failed Dissolution Specifications

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61

Brand / company
The Harvard Drug Group LLC
Codes / lots
Lot # N02425, Exp Date: 05/31/2027.
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 22 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.